BSX
BOSTON SCIENTIFIC CORP
NYSE · Healthcare · Medical - Devices · US
$45.82
+5.33%Forward multiples
Based on analyst estimates
- P/E forward
- 14.83x
- P/E 2026E
- 14.49x
- P/E 2027E
- 14.59x
- P/E 2028E
- 13.61x
- P/S forward
- 3.21x
Trailing multiples
Trailing twelve months
- P/E TTM
- 19.33x
- PEG TTM
- 0.64x
- Price / book
- 2.59x
- Price / sales
- 3.15x
- Price / cash flow
- 15.69x
Enterprise value
- Enterprise value
- $78.0B
- EV / sales
- 3.70x
- EV / EBITDA
- 14.41x
- EV / EBIT
- 17.59x
- Market cap
- $66.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026